ClariVest Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

ClariVest Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-147,282	Closed	-$1.22M	–	734
2019 Q3	$1.22M	Sell	147,282 -2,000	-1%	-$16.2K	0.03%	325
2019 Q2	$1.28M	Buy	149,282 +48,264	+48%	+$432K	0.03%	289
2019 Q1	$1.08M	Sell	101,018 -16,310	-14%	-$175K	0.02%	389
2018 Q4	$1.03M	Buy	117,328 +40,066	+52%	+$510K	0.02%	390
2018 Q3	$1.3M	Sell	77,262 -71,635	-48%	-$1.55M	0.02%	380
2018 Q2	$3.12M	Sell	148,897 -71,021	-32%	-$1.32M	0.05%	274
2018 Q1	$3.54M	Sell	219,918 -24,631	-10%	-$488K	0.06%	243
2017 Q4	$4.63M	Sell	244,549 -37,475	-13%	-$679K	0.08%	197
2017 Q3	$3.97M	Buy	282,024 +40,115	+17%	+$363K	0.09%	204
2017 Q2	$1.8M	Sell	241,909 -141	-0.1%	-$921	0.04%	294
2017 Q1	$1.57M	Buy	+242,050	New	+$1.35M	0.04%	297

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClariVest Asset Management's SPPI Position: Q4 2019 in Review

ClariVest Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2019, closing a stake of 147,282 shares — an estimated $1.22M sold.

ClariVest Asset Management first reported a position in SPPI in Q1 2017 and held it in 11 quarters. The position peaked at $4.63M in Q4 2017. 169 funds tracked by Wall St. Rank hold SPPI as of Q4 2019.

ClariVest Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
ClariVest Asset Management sold 147,282 Spectrum Pharmaceuticals Inc shares in Q4 2019, an estimated $1.22M.
ClariVest Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2017 and held it in 11 quarters.
ClariVest Asset Management's Spectrum Pharmaceuticals Inc position peaked at $4.63M in Q4 2017.
169 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2019.

Based on ClariVest Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.